Please login to the form below

Not currently logged in
Email:
Password:

pain treatment

This page shows the latest pain treatment news and features for those working in and with pharma, biotech and healthcare.

Lilly launches migraine med Reyvow at $640 per eight-pill pack

Lilly launches migraine med Reyvow at $640 per eight-pill pack

Everyone deserves freedom from the pain and symptoms of this crippling disease,” he added. ... In clinical trials, 28%-39% of patients on Reyvow treatment achieved complete relief from migraine pain after two hours, compared to 15% and 21% in the

Latest news

  • Nektar’s opioid analgesic slammed with FDA panel rejection Nektar’s opioid analgesic slammed with FDA panel rejection

    The application for the drug – NKTR-181 – was submitted as a treatment for chronic lower back pain. ... According to Nektar, NKTR-181 provides the same levels of pain relief as standard opioid products, but with reduced central nervous system (CNS)

  • NHS plans to cut certain routine tests as part of cost-saving efforts NHS plans to cut certain routine tests as part of cost-saving efforts

    According to The Guardian,  patients will be encouraged to use physiotherapy or painkillers as treatment for arthritic pain as opposed to an exploratory operation called arthroscopy. ... However, The Patients Association has raised concerns that if

  • J&J found liable in first opioid mis-marketing verdict J&J found liable in first opioid mis-marketing verdict

    marketing to disseminate the messages that pain was under-treated and ‘there was a low risk of abuse and a low danger’ of prescribing opioids”. ... and effective. As a result, these groups advocated for increased treatment of chronic pain, with a

  • Daiichi Sankyo starts mirogabalin trial in spinal injury pain Daiichi Sankyo starts mirogabalin trial in spinal injury pain

    The non-opioid painkiller was registered in Japan under the Tarlige brand name as a treatment for diabetic peripheral neuropathic pain (PNP) and postherpetic neuralgia (PHN) in January, and is a ... Around three-quarters of spinal cord injury patients

  • Brexit contributes to surge in generic drug prices Brexit contributes to surge in generic drug prices

    He says some medicines would be “particularly vulnerable" - highlighting a current shortage of pain and opioid addiction treatment Buprenorphine and antipsychotic Risperidone, arising in particular because there are no simple alternatives

More from news
Approximately 2 fully matching, plus 104 partially matching documents found.

Latest Intelligence

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    One potential major product launch for 2019 will be novel pain drug tanezumab. ... These new products will help offset the patent expiry of one of Pfizer’s biggest products, pain treatment Lyrica, which will see generics arrive at the end of December.

  • Mobile health and patient outcomes Mobile health and patient outcomes

    Putting the humanity back into patient care. Healthcare professionals, scientists and pharmaceutical companies’ understanding of the daily impact of disease and treatment on a person’s life are not always as ... In a recent study in rheumatoid

  • Deal Watch - May 2017 Deal Watch - May 2017

    its bupivacaine collagen implant for treatment of post-operative pain. ... 1, 050. Akebia (US). Otsuka (JP). Licence expansion selected countries. Vadadustat in phase 3 for treatment of anaemia.

  • Deal Watch February 2017 Deal Watch February 2017

    Cynosure's portfolio of more than 20 products covers areas such as non-invasive body contouring (including SculpSure, an FDA approved laser treatment for body contouring), hair removal, skin revitalisation and ... Combined the five products cover eight

  • Oral biologics delivery still elusive Oral biologics delivery still elusive

    Cara Therapeutics has a chronic pain treatment based on a peptide that is rendered orally bioavailable using Enteris Biopharma's Peptelligence platform, which combines a permeation enhancer and a calcium chelator ... As the intestines don't have sharp

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • THE OTHER SIDE OF … GOUT

    Doctors’ goals, on the other hand, seem to be lower. “Keep doing what you are doing”, they tell Jan when she complains about her pain, continuing to prescribe the same treatment. ... work to shift beliefs and increase motivation to improve care and

  • Virtual reality—a change for the better in medical education

    VR’s usefulness in cancer treatment doesn’t just extend into pain management. ... The impact of virtual reality distraction on pain and anxiety during dental treatment in 4–6 year-old children: a randomized controlled clinical trial.

  • 6 things that doctors want

    Doctors want a stronger collaboration with industry with the objective of raising the quality of patient care and improving treatment outcomes.What this means is that the barriers to healthcare professional ... adherence conditions like hypertension–

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics